Please provide your email address to receive an email when new articles are posted on . A wide array of potential etiologies can cause lung disease in rheumatoid arthritis patients, according to a ...
Patients with rheumatoid arthritis (RA) and RA-interstitial lung disease are at an increased risk of lung cancer, according to the results of a retrospective, matched cohort study. "Prior studies have ...
Please provide your email address to receive an email when new articles are posted on . RA-ILD was associated with an increased risk for infection vs. RA without lung disease. RA-associated ...
Rheumatoid arthritis (RA) is linked with over a 50% increased risk for lung cancer, with those having RA-associated interstitial lung disease (RA-ILD) being particularly vulnerable, facing nearly a ...
Analysis included 72,795 Veterans Health Administration patients with RA and 633,937 matched non-RA persons. HealthDay News — Rheumatoid arthritis (RA) is associated with a significantly increased ...
The therapeutic drug pirfenidone has been found to be a potential treatment for rheumatoid arthritis-associated interstitial lung disease by researchers at Baylor College of Medicine, National Jewish ...
A new study lends insights into the prevalence of lung abnormalities in patients with newly diagnosed cases of rheumatoid arthritis (RA). A high percentage of patients with early rheumatoid arthritis ...
Older age, male sex, and seropositivity are linked to a higher risk for rheumatoid arthritis– interstitial lung disease (RA-ILD) with a usual interstitial pneumonia (UIP) pattern, while only ...
Lung ultrasound is effective for detecting ILD in RA patients, with high sensitivity and moderate specificity. B-lines are a primary criterion for ILD diagnosis in LUS, indicating pulmonary ...
Identification of peripheral blood markers of disease is a significant tool in many of our rheumatologic diseases due to the relative ease of a blood draw. In rheumatoid arthritis (RA) specifically, ...
For the first time, researchers have shown that a class of anti-fibrotic drugs slows the progression of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA). Research conducted, ...
People with rheumatoid arthritis (RA) are at a higher risk for infections, including COVID-19. The risk of getting COVID is particularly high during RA flare-ups when the immune system is already ...